Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis

Abstract Background There are conflicting findings regarding the risk of acute kidney injury (AKI) and mortality with vancomycin/piperacillin-tazobactam combination (VPT) and vancomycin/meropenem (VM). The aim of this meta-analysis was to compare the risk of AKI and mortality between VPT and VM. Met...

Полное описание

Библиографические подробности

Главные авторы:	Abdulmajeed M. Alshehri, Majed S. Al Yami, Atheer Aldairem, Lama Alfehaid, Abdulaali R. Almutairi, Omar A. Almohammed, Amal Mohammad Badawoud
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-01-01
Серии:	BMC Infectious Diseases
Предметы:	Vancomycin Beta-lactams Piperacillin-tazobactam Meropenem Acute kidney injury Nephrotoxicity
Online-ссылка:	https://doi.org/10.1186/s12879-024-10227-0
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!